https://stock.noler.com/us/stock/angiogenex-inc https://stock.noler.com/us/stock/angiogenex-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/angiogenex-inc/accrued-insurance-current https://stock.noler.com/us/stock/angiogenex-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/angiogenex-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/angiogenex-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/angiogenex-inc/additional-paid-in-capital https://stock.noler.com/us/stock/angiogenex-inc/cash https://stock.noler.com/us/stock/angiogenex-inc/cash-and-equivalents https://stock.noler.com/us/stock/angiogenex-inc/cash-flow-breakdown https://stock.noler.com/us/stock/angiogenex-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/angiogenex-inc/common-stock-value https://stock.noler.com/us/stock/angiogenex-inc/compensation-expense-excluding-cost-of-good-and-service-sold https://stock.noler.com/us/stock/angiogenex-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/angiogenex-inc/current-assets https://stock.noler.com/us/stock/angiogenex-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/angiogenex-inc/current-liabilities https://stock.noler.com/us/stock/angiogenex-inc/debt-fair-value https://stock.noler.com/us/stock/angiogenex-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/angiogenex-inc/due-to-related-parties-current https://stock.noler.com/us/stock/angiogenex-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/angiogenex-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/angiogenex-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/angiogenex-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/angiogenex-inc/financing-cash-flow https://stock.noler.com/us/stock/angiogenex-inc/form-d-other https://stock.noler.com/us/stock/angiogenex-inc/general-and-administrative-expense https://stock.noler.com/us/stock/angiogenex-inc/income-taxes-paid https://stock.noler.com/us/stock/angiogenex-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/angiogenex-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/angiogenex-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/angiogenex-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/angiogenex-inc/insider-transactions-warrants https://stock.noler.com/us/stock/angiogenex-inc/interest-expense https://stock.noler.com/us/stock/angiogenex-inc/interest-expense-other https://stock.noler.com/us/stock/angiogenex-inc/interest-expense-short-term-borrowings https://stock.noler.com/us/stock/angiogenex-inc/interest-income-expense-net https://stock.noler.com/us/stock/angiogenex-inc/interest-paid https://stock.noler.com/us/stock/angiogenex-inc/interest-paid-net https://stock.noler.com/us/stock/angiogenex-inc/interest-payable-current https://stock.noler.com/us/stock/angiogenex-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/angiogenex-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/angiogenex-inc/liabilities-noncurrent https://stock.noler.com/us/stock/angiogenex-inc/loans-payable-current https://stock.noler.com/us/stock/angiogenex-inc/long-term-notes-payable https://stock.noler.com/us/stock/angiogenex-inc/net-change-in-cash https://stock.noler.com/us/stock/angiogenex-inc/net-income https://stock.noler.com/us/stock/angiogenex-inc/notes-payable-current https://stock.noler.com/us/stock/angiogenex-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/angiogenex-inc/operating-cash-flow https://stock.noler.com/us/stock/angiogenex-inc/operating-expenses https://stock.noler.com/us/stock/angiogenex-inc/operating-income https://stock.noler.com/us/stock/angiogenex-inc/other-expenses https://stock.noler.com/us/stock/angiogenex-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/angiogenex-inc/preferred-shares-facts https://stock.noler.com/us/stock/angiogenex-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/angiogenex-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/angiogenex-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/angiogenex-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/angiogenex-inc/preferred-stock-value https://stock.noler.com/us/stock/angiogenex-inc/prepaid-expense-current https://stock.noler.com/us/stock/angiogenex-inc/pretax-income-domestic https://stock.noler.com/us/stock/angiogenex-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/angiogenex-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/angiogenex-inc/public-float https://stock.noler.com/us/stock/angiogenex-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/angiogenex-inc/research-and-development https://stock.noler.com/us/stock/angiogenex-inc/retained-earnings https://stock.noler.com/us/stock/angiogenex-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/angiogenex-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-10-12g https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-10-k https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-10-q https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-10ksb https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-10qsb https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-15-12g https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-8-k https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-def-14a https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-def-14c https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-ntn-10q https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/angiogenex-inc/sec-filings-revoked https://stock.noler.com/us/stock/angiogenex-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/angiogenex-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/angiogenex-inc/shareholders-equity https://stock.noler.com/us/stock/angiogenex-inc/shares-authorized https://stock.noler.com/us/stock/angiogenex-inc/shares-issued https://stock.noler.com/us/stock/angiogenex-inc/shares-issued-2 https://stock.noler.com/us/stock/angiogenex-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/angiogenex-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/angiogenex-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/angiogenex-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/angiogenex-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/angiogenex-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/angiogenex-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/angiogenex-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/angiogenex-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/angiogenex-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/angiogenex-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/angiogenex-inc/taxes-and-licenses https://stock.noler.com/us/stock/angiogenex-inc/total-assets https://stock.noler.com/us/stock/angiogenex-inc/total-liabilities https://stock.noler.com/us/stock/angiogenex-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/angiogenex-inc/weighted-average-number-of-share-outstanding-basic-and-diluted